Literature DB >> 10417261

Antigenic epitopes of the hepatitis A virus polyprotein.

Y E Khudyakov1, E N Lopareva, D L Jue, S Fang, J Spelbring, K Krawczynski, H S Margolis, H A Fields.   

Abstract

Forty-two antigenic domains were identified across the hepatitis A virus (HAV) polyprotein by using a set of 237 overlapping 20-mer synthetic peptides spanning the entire HAV polyprotein and a panel of serum samples from acutely HAV-infected patients. The term "antigenic domain" is used in this study to define a protein region spanned with consecutive overlapping immunoreactive peptides. Nineteen antigenic domains were found within the structural proteins, and 22 were found within the nonstructural proteins, with 1 domain spanning the junction of VP1 and P2A proteins. Five of these domains were considered immunodominant, as judged by both the breadth and the strength of their immunoreactivity. One domain is located within the VP2 protein at position 57-90 aa. A second domain, located at position 767-842 aa, contains the C-terminal part of the VP1 protein and the entire P2A protein. A third domain, located at position 1403-1456 aa, comprises the C-terminal part of the P2C protein and the N-terminal half of the P3A protein. The fourth domain, located at position 1500-1519 aa, includes almost the entire P3B, and the last domain, located at position 1719-1764 aa, contains the C-terminal region of the P3C protein and the N-terminal region of the P3D protein. It is interesting to note that four of the five most immunoreactive domains are derived from small HAV proteins and/or encompass protein cleavage sites separating different HAV proteins. The HAV-specific immunoreactivity of each antigenically reactive peptide was confirmed by using seven HAV seroconversion panels. Collectively, these data demonstrate that HAV structural and nonstructural proteins contain antigenic epitopes that can be efficiently modeled with short synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417261     DOI: 10.1006/viro.1999.9813

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein.

Authors:  Mauro Costa-Mattioli; Juan Cristina; Héctor Romero; Raoul Perez-Bercof; Didier Casane; Rodney Colina; Laura Garcia; Ines Vega; Graciela Glikman; Victor Romanowsky; Alejandro Castello; Elisabeth Nicand; Michelle Gassin; Sylviane Billaudel; Virginie Ferré
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study.

Authors:  C Ye; J Luo; X Wang; J Xi; Y Pan; J Chen; X Yang; G Li; Q Sun; J Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-19       Impact factor: 3.267

3.  Genetic analysis of HAV strains in Tunisia reveals two new antigenic variants.

Authors:  Hakima Gharbi-Khelifi; Khira Sdiri; Rafik Harrath; Lamia Fki; Hèla Hakim; Mathilde Berthomé; Sylviane Billaudel; Virginie Ferre; Mahjoub Aouni
Journal:  Virus Genes       Date:  2007-03-29       Impact factor: 2.332

4.  Solubility as a limiting factor for expression of hepatitis A virus proteins in insect cell-baculovirus system.

Authors:  Haroldo Cid da Silva; Cristiane Pinheiro Pestana; Ricardo Galler; Marco Alberto Medeiros
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-07-11       Impact factor: 2.743

5.  Expression of recombinant rotavirus proteins harboring antigenic epitopes of the hepatitis a virus polyprotein in insect cells.

Authors:  Van Thai Than; In Hyuk Baek; Hee Young Lee; Jong Bum Kim; Dong Hwa Shon; In Sik Chung; Wonyong Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.